Previous close | 979.60 |
Open | 981.80 |
Bid | 974.80 x 0 |
Ask | 980.80 x 0 |
Day's range | 981.80 - 981.80 |
52-week range | 627.50 - 998.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights The projected fair value for Regeneron Pharmaceuticals is US$1,936 based on 2 Stage Free Cash Flow to...
Regeneron (REGN) maintains momentum on the back of Dupixent profits and efforts to develop oncology portfolio despite near-term challenges.
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...